© 2020 MJH Life Sciences™ and Cancer Network. All rights reserved.
Author | Sanoj Punnen, MD, MAS
Articles
Point: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?
June 19, 2019
In this Point/Counterpoint, Drs. Bhat and Punnen argue that active surveillance can be beneficial for patients with intermediate-risk prostate cancer.